Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development
EuPA Open Proteomics · 2014
DOI: 10.1016/j.euprot.2014.02.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift EuPA Open Proteomics, 2014. Verfasst von Melinda Rezeli und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0). Gefördert von: Swedish Academy of Pharmaceutical Sciences, Swedish Research Council, Bagadilico.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Swedish Academy of Pharmaceutical Sciences
- Swedish Research Council
- Bagadilico
- Vinnova
- Ingabritt & Arne Lundbergs forskningsstiftelse
- Crafoord Foundation
Zitieren
APA
Rezeli, M., Végvári, Á., Silajdžić, E., Björkqvist, M., Tabrizi, S. J., Laurell, T., & Marko-Varga, G. (2014). Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development. EuPA Open Proteomics. https://doi.org/10.1016/j.euprot.2014.02.003
Vancouver
Rezeli M, Végvári Á, Silajdžić E, Björkqvist M, Tabrizi SJ, Laurell T, et al. Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development. EuPA Open Proteomics. 2014. doi:10.1016/j.euprot.2014.02.003
BibTeX
@article{Rezeli2014,
author = {Rezeli, Melinda and Végvári, Ákos and Silajdžić, Edina and Björkqvist, Maria and Tabrizi, Sarah J. and Laurell, Thomas and Marko-Varga, György},
title = {Inflammatory markers in Huntington's disease plasma—A robust nanoLC–MRM-MS assay development},
journal = {EuPA Open Proteomics},
year = {2014},
doi = {10.1016/j.euprot.2014.02.003}
}
EUVIMED